1 option
Guide to Cancer Immunotherapy.
- Format:
- Book
- Author/Creator:
- Walker, Suzanne.
- Language:
- English
- Subjects (All):
- Neoplasms--therapy.
- Neoplasms--nursing.
- Immunotherapy--nursing.
- Oncology Nursing--methods.
- Medical Subjects:
- Neoplasms--therapy.
- Neoplasms--nursing.
- Immunotherapy--nursing.
- Oncology Nursing--methods.
- Physical Description:
- 1 online resource (450 pages)
- Edition:
- 2nd ed.
- Place of Publication:
- Pittsburgh : Oncology Nursing Society, 2025.
- Summary:
- Dive into the principles of immunotherapy, relevant biomarkers, and up-to-date information on immunotherapies, including checkpoint inhibitors and cytokine therapies, with the latest edition of ONS's Guide to Cancer Immunotherapy.
- Contents:
- Intro
- Preface
- Acknowledgments
- Chapter 1. History of Immunotherapy
- Introduction
- The First Hint Toward Immunotherapy
- 1900s-1970s: From Coley Toxins to a Renewed Look at Immunotherapy
- 1980s-1990s: Immunotherapy Comes of Age
- 2000s: Discoveries at the Bench Translate to Immunotherapy Advances at the Bedside
- Summary
- References
- Chapter 2. Principles of Immunology and Immunotherapy
- Immunologic Tolerance
- Cancer and the Immune System
- Chapter 3. Biomarkers
- Cancer-Related Alterations and Biomarkers
- Sources and Testing
- Clinical Applications
- Immunotherapy and Biomarkers
- Nursing Implications
- Chapter 4. Immune Checkpoint Inhibitors
- Checkpoint Receptors
- Checkpoint Inhibitors
- Other Promising Checkpoint Inhibitors
- Dosing and Administration
- Adverse Events
- Pregnancy and Lactation
- Chapter 5. Oral Immunomodulatory Agents
- History
- Mechanism of Action
- Risk Evaluation and Mitigation Strategy
- Chapter 6. Active Immunity: Vaccine Therapy
- History of Vaccines
- The Mechanism of Cancer Vaccines
- Vaccine Development
- Prophylactic Versus Therapeutic Vaccines
- Therapeutic Cancer Vaccines
- Challenges Facing Vaccine Therapy
- Chapter 7. Monoclonal Antibodies
- Tumor-Targeting Monoclonal Antibodies
- Epidermal Growth Factor Receptor-Specific Monoclonal Antibodies
- HER2-Targeted Monoclonal Antibodies
- Vascular Endothelial Growth Factor Receptor Inhibitors
- Platelet-Derived Growth Factor Alpha Inhibitors
- CD19-Targeted Monoclonal Antibodies
- CD20-Targeted Monoclonal Antibodies
- SLAMF7-Targeted Antibodies.
- CD38-Targeted Monoclonal Antibodies
- Interleukin-6-Targeted Monoclonal Antibodies
- CD52-Targeted Antibodies
- Receptor Activator of Nuclear Factor Kappa-B Ligand
- Antibody-Drug Conjugates
- Antibody-Radiopharmaceutical Conjugates
- Immunotoxin Therapy
- New and Emerging Antibody Therapies
- Infusion-Related Reactions
- Chapter 8. Adoptive T Cells and Bispecific T-Cell Engager Antibodies
- Adoptive T-Cell Therapies: Chimeric Antigen Receptor T Cells
- Chimeric Antigen Receptor T-Cell Products
- Adoptive T-Cell Therapies: Tumor-Infiltrating Lymphocytes
- Adoptive T-Cell Therapies: T-Cell Receptors
- Bispecific T-Cell Engager Antibodies
- Chapter 9. Bacillus Calmette-Guérin
- Dosing
- Contraindications to Treatment
- Nursing Considerations, Administration, and Patient Instructions
- Side Effects
- Chapter 10. Cytokines in Immunotherapy
- Cytokines and Cytokine Function
- Chemokines
- Types of Cytokines
- Cytokines and Cancer Symptoms
- Chapter 11. Case-Based Management Strategies and Special Considerations
- Immune-Related Adverse Events From Checkpoint Inhibitors
- Immune-Related Adverse Events From Other Agents
- Special Considerations
- Patient Education
- Bookmark 8
- Index.
- Notes:
- Description based on publisher supplied metadata and other sources.
- ISBN:
- 9781635930665
- 1635930669
- OCLC:
- 1511107900
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.